Last reviewed · How we verify

NCT05097118

Surgical Site Infiltration Using Ketamine Versus Bupivacaine for Analgesia in Post-operative Appendectomy Operation

Completed EARLY_PHASE1 Last updated 18 October 2022
What this trial tests

EARLY_PHASE1 trial testing Ketamine Versus Bupivacaine in Appendicitis Acute in 60 participants. Completed in 1 May 2022.

Timeline
1 September 2021
Primary endpoint
1 May 2022
1 May 2022

Quick facts

Lead sponsorSohag University
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 September 2021
Primary completion1 May 2022
Estimated completion1 May 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 14 to 50, any sex, with Appendicitis Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

surgical site infiltration using ketamine versus Bupivacaine for analgesia in post-operative Appendectomy operation by Ketamine versus Bupivacaine

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Appendicitis Acute

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05097118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing